全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

A Case of Fahr’s Disease with Epilepsy as the First Symptom in Infancy

DOI: 10.4236/crcm.2024.134012, PP. 101-107

Keywords: Fahr, Primary Familial Brain Calcification, Epilepsy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Fahr’s disease, also recognized as Idiopathic Basal Ganglia Calcification (IBGC) or Primary Familial Brain Calcification (PFBC), was first identified by the German neurologist Karl Theodor Fahr in 1930. This rare condition, which involves the calcification of the basal ganglia and presents significant treatment challenges, is most commonly diagnosed in middle-aged adults and is notably uncommon in children. Purpose: We report a case of a younger patient and review this disease as an aid to early detection and diagnosis of the disease. Case Introduction: In this report, we present a unique case of Fahr’s disease in a child, where epilepsy manifested as the initial symptom during infancy. In this report, we present a case of Fahr’s disease in a child who presented with epilepsy as the first symptom in infancy. The child had no imaging abnormalities at the onset of the seizure, and subsequent antiepileptic drugs were reduced and discontinued, and when the seizure recurred 3 years later, a perfect cranial CT revealed symmetrical calcifications in the brain, which gradually worsened, and subsequently the child was unable to take care of himself and had regression of his psychomotor development, and the family requested discharge from the hospital, and then the child died during the follow-up visit. Conclusion: The disease is currently associated with a number of disorders for which there is no specific treatment, and half of all patients currently have a well-defined gene, emphasizing more importantly the importance of genetic counseling for parents known to be at risk prior to conception.

References

[1]  Siddiqui, W.T., Brar, G. and Bilori, B. (2022) Fahr’s Disease. Postgraduate Medical Journal, 98, e39.
https://doi.org/10.1136/postgradmedj-2021-140309
[2]  Saengow, V.E., Chiangjong, W., Khongkhatithum, C., et al. (2021) Proteomic Analysis Reveals Plasma Haptoglobin, Interferon-γ, and Interleukin-1β as Potential Biomarkers of Pediatric Refractory Epilepsy. Brain and Development, 43, 431-439.
https://doi.org/10.1016/j.braindev.2020.11.001
[3]  Inden, M., Kurita, H. and Hozumi, I. (2022) Characteristics and Therapeutic Potential of Sodium-Dependent Phosphate Cotransporters in Relation to Idiopathic Basal Ganglia Calcification. Journal of Pharmacological Sciences, 148, 152-155.
https://doi.org/10.1016/j.jphs.2021.11.004
[4]  Khalid, S., Khan, S.A., Khan, A.H., et al. (2020) Fahr’s Disease in a Patient Presenting with Status Epilepticus. Journal of Ayub Medical College Abbottabad, 32, 280-282.
[5]  Carecchio, M., Mainardi, M. and Bonato, G. (2023) The Clinical and Genetic Spectrum of Primary Familial Brain Calcification. Journal of Neurology, 270, 3270-3277.
https://doi.org/10.1007/s00415-023-11650-0
[6]  Grangeon, L., Wallon, D., Charbonnier, C., et al. (2019) Biallelic MYORG Mutation Carriers Exhibit Primary Brain Calcification with a Distinct Phenotype. Brain, 142, 1573-1586.
https://doi.org/10.1093/brain/awz095
[7]  Manea, M.M., Sirbu, A., et al. (2020) Epileptic Seizures as te First Manifestation of Fahr’s Syndrome. Acta Endocrinologica (Bucharest), 16, 370-374.
https://doi.org/10.4183/aeb.2020.370
[8]  Nicolas, G., Pottier, C., Charbonnier, C., et al. (2013) Phenotypic Spectrum of Probable and Genetically-Confirmed Idiopathic Basal Ganglia Calcification. Brain, 136, 3395-3407.
https://doi.org/10.1093/brain/awt255
[9]  Sudan, S., Sebastian, S.A. and Co, E.L. (2022) Fahr’s Disease with an Atypical Onset of Epileptic Seizure. Radiology Case Reports, 17, 3139-3141.
https://doi.org/10.1016/j.radcr.2022.06.003
[10]  Nitschke, Y. and Rutsch, F. (2017) Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts. Current Osteoporosis Reports, 15, 255-270.
https://doi.org/10.1007/s11914-017-0370-3
[11]  Keasey, M.P., Lemos, R.R., Hagg, T., et al. (2016) Vitamin-D Receptor Agonist Calcitriol Reduces Calcification in Vitro through Selective Upregulation of SLC20A2 But Not SLC20A1 or XPR1. Scientific Reports, 6, Article No. 25802.
https://doi.org/10.1038/srep25802

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133